Medicare Enrolled

Dr. Courtney Csikesz, M.D.

Dermatology · Weymouth, MA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
90 LIBBEY PKWY, Weymouth, MA 02189
7813359700
In practice since 2009 (17 years)
NPI: 1760619902 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Csikesz from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Csikesz? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Csikesz

Dr. Courtney Csikesz is a dermatology specialist in Weymouth, MA, with 17 years of NPI registration. Based on federal Medicare data, Dr. Csikesz performed 12,931 Medicare services across 2,295 unique beneficiaries.

Between the years covered by Open Payments, Dr. Csikesz received a total of $15,950 from 43 pharmaceutical and/or device companies across 752 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in dermatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Csikesz is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 17 years in practice ▲ Top 3% volume in MA $15,950 industry payments

Medicare Practice Summary

Medicare Utilization ↗
12,931
Medicare services
Top 3% in MA for dermatology
2,295
Unique beneficiaries
$18
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~761 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Photodynamic therapy gel for precancerous skin 8,600 $1 $4
Destruction of precancerous skin growths, 2-14
This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer.
1,937 $6 $50
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
670 $73 $200
Destruction of precancerous skin growth, 1
Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer.
581 $49 $200
Skin biopsy, tangential
A procedure to remove a sample of the first identified skin growth for laboratory examination.
200 $81 $274
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
194 $106 $300
Destruction of skin growths (warts/lesions), 1-14
This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface.
185 $101 $300
Intermediate wound repair, 2.6-7.5 cm
A medical procedure to close a wound on the scalp, underarms, trunk, arms, or legs that measures between 2.6 and 7.5 centimeters. This type of repair involves cleaning the wound and stitching it closed to promote healing.
106 $266 $796
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
101 $44 $150
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
95 $86 $270
Surgical removal of skin cancer, 1.1-2.0 cm
Surgical excision of a cancerous skin growth measuring between 1.1 and 2.0 centimeters on the body, arms, or legs.
84 $115 $632
Additional skin growth biopsy
Removal of a sample of an additional skin growth for laboratory examination. This code is used for each extra lesion biopsied during the same session.
49 $46 $200
Destruction of 15 or more precancerous skin growths
This procedure involves the removal or destruction of fifteen or more precancerous skin lesions. It is performed to treat abnormal skin cells that have the potential to develop into cancer.
44 $150 $500
Light application with debridement to destroy precancerous skin growth
This procedure involves applying light to the skin along with debridement to destroy precancerous skin growths.
37 $256 $790
Surgical removal of skin cancer, 2.1-3.0 cm
This procedure involves the surgical excision of a cancerous skin growth located on the body, arms, or legs. The size of the removed tissue measures between 2.1 and 3.0 centimeters.
18 $129 $712
New patient office visit, 15-29 minutes
An initial office visit for a new patient lasting 15 to 29 minutes. This code is used when the total time spent on the date of the encounter meets this duration threshold.
16 $52 $180
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
14 $85 $400
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$15,950
Total received (2018-2024)
Avg $2,279/year across 7 years
Top 12% in MA for dermatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
43
Companies
752
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$15,821 (99.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$129 (0.8%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,981
2023
$3,248
2022
$2,641
2021
$2,258
2020
$1,145
2019
$1,884
2018
$1,794

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$705
E.R. Squibb & Sons, L.L.C.
$349
Incyte Corporation
$250
LEO Pharma Inc.
$230
GENZYME CORPORATION
$186
Regeneron Healthcare Solutions, Inc.
$185
SUN PHARMACEUTICAL INDUSTRIES INC.
$173
Dermavant Sciences, Inc.
$145
Lilly USA, LLC
$142
Galderma Laboratories, L.P.
$102
Amgen Inc.
$90
UCB, Inc.
$89
STRATA Skin Sciences, Inc.
$64
Novartis Pharmaceuticals Corporation
$62
Arcutis Biotherapeutics, Inc.
$48
Verrica Pharmaceuticals Inc.
$43
Ortho Dermatologics, a division of Bausch Health US, LLC
$35
Boehringer Ingelheim Pharmaceuticals, Inc.
$29
Janssen Biotech, Inc.
$20
PFIZER INC.
$19
Helsinn Therapeutics (U.S.), Inc.
$15
Top 3 companies account for 43.7% of 2024 payments
All-time payments by company (2018-2024) ›
LEO Pharma Inc.
$1,960
ABBVIE INC.
$1,302
AbbVie Inc.
$1,239
Novartis Pharmaceuticals Corporation
$1,132
Janssen Biotech, Inc.
$997
Incyte Corporation
$839
GENZYME CORPORATION
$757
Regeneron Healthcare Solutions, Inc.
$724
Lilly USA, LLC
$664
E.R. Squibb & Sons, L.L.C.
$622
PFIZER INC.
$594
AbbVie, Inc.
$523
Amgen Inc.
$508
Sun Pharmaceutical Industries Inc.
$409
Allergan Inc.
$361
Galderma Laboratories, L.P.
$357
UCB, Inc.
$346
Celgene Corporation
$296
SUN PHARMACEUTICAL INDUSTRIES INC.
$237
Merz North America, Inc.
$199
MERZ NORTH AMERICA, INC.
$177
Dermavant Sciences, Inc.
$175
Allergan, Inc.
$149
Boehringer Ingelheim Pharmaceuticals, Inc.
$143
Arcutis Biotherapeutics, Inc.
$136
Ortho Dermatologics, a division of Bausch Health US, LLC
$126
Biofrontera Inc.
$122
DUSA Pharmaceuticals, Inc.
$111
Mayne Pharma Inc.
$109
Janssen Scientific Affairs, LLC
$104
VYNE Pharmaceuticals Inc.
$101
Genentech USA, Inc.
$72
Verrica Pharmaceuticals Inc.
$67
STRATA Skin Sciences, Inc.
$64
Almirall LLC
$44
Blueprint Medicines Corporation
$42
Mission Pharmacal Company
$29
Helsinn Therapeutics (U.S.), Inc.
$27
Pierre Fabre Pharmaceuticals, Inc.
$25
Bayer HealthCare Pharmaceuticals Inc.
$20
Surgical Specialties Corporation (US), Inc.
$15
Mylan Pharmaceuticals Inc.
$14
Merck Sharp & Dohme Corporation
$11
Top 3 companies account for 28.2% of all-time payments
Associated products mentioned in payments ›
20% · ABSORICA (isotretinoin) · ADBRY · AKLIEF · AMELUZ · AMZEEQ · ARAZLO · Aczone · Ameluz · Avar · BLU-U · BLU-U Blue Light Photodynamic Therapy Illuminator Model 4170 · BOTOX · BOTOX COSMETIC · Bimzelx · COSENTYX · Cimzia · DORYX · DUOBRII · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · ENSTILAR · EPIDUO FORTE · EPSOLAY · EUCRISA · Erivedge · FINACEA · Finacea · HUMIRA · Humira · ILUMYA · Ilumya · JUBLIA · LIBTAYO · Levulan Kerastick (aminolevulinic acid HCl) for Topical Solution · ODOMZO · OLUMIANT · OPZELURA · ORACEA · Olux-E · Otezla · PICATO · REMICADE · RETIN-A · RINVOQ · SIVEXTRO · SKYRIZI · SOOLANTRA · SPEVIGO · Seysara · Skyrizi · Sotyktu · Surgical wound closure product · TALTZ · TREMFYA · TWYNEO · Tremfya · VALCHLOR · VTAMA · Winlevi · XEOMIN · XTRAC · Xeomin · YCANTH · Zoryve
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a dermatology specialist in Weymouth?
Compare dermatologists in the Weymouth area by procedure volume, costs, and industry payment transparency.
Browse dermatologists nearby

Geographic Context

Dermatologists within 10 mi
374
Per 100K population
51.6
County median income
$126,497
Nearest hospital
SOUTH SHORE HOSPITAL
3.3 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Csikesz is a mixed practice specialist, with above-average Medicare volume (top 3% in MA), with low-engagement industry engagement in the top 12% of MA peers, with 17 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Csikesz experienced with photodynamic therapy gel for precancerous skin?
Based on Medicare claims data, Dr. Csikesz performed 8,600 photodynamic therapy gel for precancerous skin services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Csikesz receive payments from pharmaceutical companies?
Yes. Dr. Csikesz received a total of $15,950 from 43 companies across 752 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Csikesz's costs compare to other dermatologists in Weymouth?
Dr. Csikesz's average Medicare payment per service is $18. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Csikesz) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →